Open-Label Clinical Trials Have Higher Cure Rate of Recurrent C. Diff Infection Compared to Randomized Clinical Trials

Randomized clinical trials still showed that microbiota restoration is significantly more effective than antibiotics for recurrent Clostridioides difficile infection.

Related Keywords

United States ,America , ,Infectious Diseases Society Of America ,Society Of Healthcare Epidemiology America ,Therapy Advancements ,Infectious Diseases Society ,Healthcare Epidemiology ,